Washington/UNI/Sputnik: The US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend the Pfizer COVID-19 vacc ...
New York: Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from ...
New York: Pfizer Inc and BioNTech SE on Monday announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11 y ...
Seoul/UNI/SPUTNIK: Around 140 people have received suspicious Pfizer vaccine shots at a general hospital in South Korea's capital of Seoul, Yonhap News Agency reported citing health o ...
Washington/Sputnik: No COVID-19 variant has escaped the protection of Pfizer's vaccine, but the company continues to monitor and test it against emerging strains around the world, CEO ...
Pfizer on Tuesday said it will begin testing its COVID-19 vaccine on a larger group of children under the age of 12.
Moscow/Sputnik: The Japanese government approved Pfizer's COVID-19 vaccine for ages 12 to 15 on Monday, the media reported.
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing fede ...
Moscow/Sputnik: The efficacy of the Pfizer coronavirus vaccine (official name BNT162b2) might sustain against the newly-detected mutant strains from the United Kingdom and South Africa, a ...
